Aarkstore -Female Hypoactive Sexual Desire Disorder-Pipeline Insights, 2014

1
Female Hypoactive Sexual Desire Disorder-Pipeline
Insights, 2014
Category Pharmaceuticals Healthcare

• Browse Complete Report -
• http//www.aarkstore.com/healthcare/77061/-female-
  hypoactive-sexual-desire-disorder-pipeline-insight
  s-2014

2
Summary

• DelveInsights, Female Hypoactive Sexual Desire
  Disorder-Pipeline Insights, 2014, report provides
  comprehensive insights about pipeline drugs
  across this indication. A key objective of the
  report is to establish the understanding for all
  the pipeline drugs that fall under Female
  Hypoactive Sexual Desire Disorder. This report
  provides information on the therapeutic
  development based on the Female Hypoactive Sexual
  Desire Disorder dealing with all the pipeline
  drugs, comparative analysis at various stages
  covering Filed, Phase III, Phase II, Phase I, IND
  filed, Preclinical, Discovery and unknown stages,
  therapeutics assessment by monotherapy and
  combination products and molecule type drug
  information. The report also covers the companies
  information involved in the therapeutic
  development of the products. It also has
  highlighted the discontinued and dormant products.

3
Summary

• Data Sources
• The report is built using data and information
  sourced from proprietary databases, primary and
  secondary research and in-house analysis by
  DelveInsight team of industry experts.Secondary
  sources information and data has been collected
  from various printable and non-printable sources
  like search engines, News websites, Government
  Websites, Trade Journals, White papers,
  Magazines, Trade associations, Books, Industry
  Portals, Industry Associations and access to
  available databases.Note This report requires
  certain updates. We have all the information
  available but require 3 business days to complete
  the process and ensure it is as up-to-date as
  possible. Certain sections in the report may be
  removed or altered based on the availability and
  relevance of data for the indicated Indication.

4
Summary

• Scope 
• The report provides a snapshot of the global
  therapeutic landscape of Female Hypoactive Sexual
  Desire DisorderThe report provides pipeline
  products under drug profile section which
  includes product description, MOA, licensors
  collaborators, development partner and chemical
  informationCoverage of the Female Hypoactive
  Sexual Desire Disorder pipeline on the basis of
  target, MOA, route of administration, technology
  involved and molecule typeThe report reviews key
  players involved in the therapeutics development
  for Female Hypoactive Sexual Desire Disorder and
  also provide company profilingThe report also
  gives the information of dormant and discontinued
  pipeline projects Pipeline products coverage
  based on various stages of development ranging
  from preregistration till discovery and
  undisclosed stages Provides pipeline assessment
  by monotherapy and combination therapy products,
  stage of development and molecule type

5
Summary

• Reasons to buyComplete Pipeline intelligence
  and complete understanding over therapeutics
  development for Female Hypoactive Sexual Desire
  Disorder
• Identify the relationship between the drugs and
  use it for target finding, drug repurposing, and
  precision medicine.
• Devise corrective measures for pipeline projects
  by understanding Female Hypoactive Sexual Desire
  Disorder pipeline depth and focus of Indication
  therapeutics
• Developing strategic initiatives to support your
  drug development activities.
• Optimize your portfolio and keep you in touch
  with the rapidly changing pharmaceutical markets,
  and make the best decisions for your business.

6
Summary

• Develop and design in licensing and out licensing
  strategies by identifying prospective partners
  with the most attractive projects to enhance and
  expand business potential and Scope
• Provides strategically significant competitor
  information, analysis, and insights to formulate
  effective RD development strategies
• Modify the therapeutic portfolio by identifying
  discontinued projects and understanding the
  factors that drove them from pipeline
• Gaining a Full Picture of the Competitive
  Landscape for Evidence based Decisions

7
Table of Content

• Female Hypoactive Sexual Desire Disorder
  OverviewFemale Hypoactive Sexual Desire Disorder
  Pipeline TherapeuticsFemale Hypoactive Sexual
  Desire Disorder Therapeutics under Development by
  Companies Female Hypoactive Sexual Desire
  Disorder Late Stage Products (Filed and Phase
  III)Comparative Analysis Female Hypoactive
  Sexual Desire Disorder Mid Clinical Stage
  Products (Phase II)Comparative Analysis Female
  Hypoactive Sexual Desire Disorder Early Clinical
  Stage Products (Phase I and IND
  Filed)Comparative Analysis Female Hypoactive
  Sexual Desire Disorder Discovery and Pre-Clinical
  Stage Products Comparative Analysis Drug
  Candidate Profiles

8
Table of Content

• Female Hypoactive Sexual Desire Disorder
  Therapeutics Assessment Assessment by
  Monotherapy Products Assessment by Combination
  Products Assessment by Route of
  Administration Assessment by Molecule
  Type Female Hypoactive Sexual Desire Disorder
  Discontinued Products Female Hypoactive Sexual
  Desire Disorder Dormant ProductsCompanies
  Involved in Therapeutics Development for Female
  Hypoactive Sexual Desire Disorder Appendix Metho
  dology Contact Us Disclaimer

9
List of Tables

• Number of Products under Development for Female
  Hypoactive Sexual Desire Disorder, 2014Number of
  Products under Development by Companies Comparati
  ve Analysis by Late Clinical Stage Products
  (Filed and Phase III), 2014Comparative Analysis
  Mid Clinical Stage Products (Phase II),
  2014Comparative Analysis Early Clinical Stage
  Products (Phase I and IND Filed),
  2014Comparative Analysis Discovery and
  Pre-Clinical Stage Products, 2014Drug Candidates
  ProfilesFemale Hypoactive Sexual Desire Disorder
  Assessment by Monotherapy Products Female
  Hypoactive Sexual Desire Disorder Assessment by
  Combination Products 

10
List of Tables

• Female Hypoactive Sexual Desire Disorder
  Assessment by Route of Administration Female
  Hypoactive Sexual Desire Disorder Assessment by
  Stage and Route of Administration Female
  Hypoactive Sexual Desire Disorder Assessment by
  Molecule Type Female Hypoactive Sexual Desire
  Disorder Assessment by Stage and Molecule
  Type Female Hypoactive Sexual Desire Disorder
  Therapeutics Discontinued Products Female
  Hypoactive Sexual Desire Disorder Therapeutics
  Dormant ProductsProducts under Development by
  Companies, 2014

11
List of Figures

• Number of Products under Development for Female
  Hypoactive Sexual Desire Disorder, 2014Late
  Clinical Stage Products (Filed and Phase III),
  2014Mid Clinical Stage Products (Phase II),
  2014Early Clinical Stage Products (Phase I and
  IND Filed), 2014Discovery and Pre-Clinical Stage
  Products, 2014Female Hypoactive Sexual Desire
  Disorder Assessment by Monotherapy
  Products Female Hypoactive Sexual Desire
  Disorder Assessment by Combination
  Products Female Hypoactive Sexual Desire
  Disorder Assessment by Route of
  Administration Female Hypoactive Sexual Desire
  Disorder Assessment by Stage and Route of
  Administration Female Hypoactive Sexual Desire
  Disorder Assessment by Molecule Type Female
  Hypoactive Sexual Desire Disorder Assessment by
  Stage and Molecule Type

12
Related Reports

• Laboratory Information Management Systems/ LIMS
  Market by Product (COTS Legacy), Delivery Mode
  (On-premise, Hosted, Cloud), Component (Software
  Services), End User Industries (Healthcare,
  CRO, Petrochemical, Oil and Gas, Chemical) -
  Forecast to 2019
• 2015 Worldwide Nursing Care Facilities
  Industry-Industry Market Report
• 2015 Worldwide Medical Surgical Hospitals
  Industry-Industry Market Report
• 2015 Worldwide Home Health Care Services
  Industry-Industry Market Report
• 2015 Worldwide Offices of Dentists
  Industry-Industry Market Report
• Ascension Health - Pharmaceuticals Healthcare -
  Deals and Alliances Profile
• Accretive Health, Inc. (ACHI) - Strategic SWOT
  Analysis Review

13

• Female Hypoactive Sexual Desire Disorder-Pipeline
  Insights, 2014
• Published Dec. 2014 60 Pages
• DelveInsights, Female Hypoactive Sexual Desire
  Disorder-Pipeline Insights, 2014, report provides
  comprehensive insights about pipeline drugs
  across this indication.
• 
  Price

Format Price
PDF 1250
Site Licence 2500
Enterprise Wide Licence 4000
14
Contact Us
Office Office No. - 809, 8th Floor,B-Wing,
Mahaavir Icon, Plot No.- 89 90,
Sector-15,CBD-Belapur, Navi Mumbai
400614, Maharashtra, India. Telefax No 91 22
4127 6660 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756 4953

• You Can Visit http//www.aarkstore.com
• OR Mail us at contact_at_aarkstore.com
• Blog
• http//www.aarkstore.com/blog/
• Conference
• http//conference.aarkstore.com/
• News
• http//www.aarkstore.com/news